Q32 Bio Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - Cambridge, USA
Description - Q32 Bio is developing drugs targeting powerful regulators of both the innate and adaptive immune systems with the goal of re-balancing the immune system.
Team
Founder Michael Broxson
Funding
Q32 Bio raised $60,000,000 with OrbiMed Advisors and Osage University Partners and Acorn Bioventures, Atlas Venture, Abingworth, Sanofi Ventures - 11/4/2020